Stock Analysis

Hangzhou Haoyue Personal Care Co., Ltd's (SHSE:605009) Prospects Need A Boost To Lift Shares

When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 38x, you may consider Hangzhou Haoyue Personal Care Co., Ltd (SHSE:605009) as a highly attractive investment with its 14.6x P/E ratio. However, the P/E might be quite low for a reason and it requires further investigation to determine if it's justified.

Recent times haven't been advantageous for Hangzhou Haoyue Personal Care as its earnings have been falling quicker than most other companies. It seems that many are expecting the dismal earnings performance to persist, which has repressed the P/E. You'd much rather the company wasn't bleeding earnings if you still believe in the business. If not, then existing shareholders will probably struggle to get excited about the future direction of the share price.

See our latest analysis for Hangzhou Haoyue Personal Care

pe-multiple-vs-industry
SHSE:605009 Price to Earnings Ratio vs Industry March 4th 2025
Keen to find out how analysts think Hangzhou Haoyue Personal Care's future stacks up against the industry? In that case, our free report is a great place to start.
Advertisement

Is There Any Growth For Hangzhou Haoyue Personal Care?

The only time you'd be truly comfortable seeing a P/E as depressed as Hangzhou Haoyue Personal Care's is when the company's growth is on track to lag the market decidedly.

Taking a look back first, the company's earnings per share growth last year wasn't something to get excited about as it posted a disappointing decline of 8.6%. Still, the latest three year period has seen an excellent 38% overall rise in EPS, in spite of its unsatisfying short-term performance. Accordingly, while they would have preferred to keep the run going, shareholders would probably welcome the medium-term rates of earnings growth.

Looking ahead now, EPS is anticipated to climb by 16% during the coming year according to the dual analysts following the company. With the market predicted to deliver 37% growth , the company is positioned for a weaker earnings result.

With this information, we can see why Hangzhou Haoyue Personal Care is trading at a P/E lower than the market. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.

The Final Word

It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

As we suspected, our examination of Hangzhou Haoyue Personal Care's analyst forecasts revealed that its inferior earnings outlook is contributing to its low P/E. At this stage investors feel the potential for an improvement in earnings isn't great enough to justify a higher P/E ratio. Unless these conditions improve, they will continue to form a barrier for the share price around these levels.

Don't forget that there may be other risks. For instance, we've identified 2 warning signs for Hangzhou Haoyue Personal Care (1 is a bit concerning) you should be aware of.

Of course, you might also be able to find a better stock than Hangzhou Haoyue Personal Care. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

Valuation is complex, but we're here to simplify it.

Discover if Hangzhou Haoyue Personal Care might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SHSE:605009

Hangzhou Haoyue Personal Care

Research, develops, manufactures, and sells women, young, and adult health care products under the haoyue brand name in China.

Excellent balance sheet and fair value.

Advertisement

Weekly Picks

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8227.1% undervalued
21 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative
WO
BMBL logo
woodworthfund on Bumble ·

Swiped Left by Wall Street: The BMBL Rebound Trade

Fair Value:US$960.0% undervalued
7 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
WE
WealthAP
DUOL logo
WealthAP on Duolingo ·

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For

Fair Value:US$268.6433.4% undervalued
24 users have followed this narrative
3 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

IN
EDV logo
InvestorNTrader on Endeavour Group ·

Endeavour Group's Future PE Expected to Climb to 15.51%

Fair Value:AU$2.8628.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BA
NVO logo
bactrian on Novo Nordisk ·

A Quality Compounder Marked Down on Overblown Fears

Fair Value:US$9540.8% undervalued
96 users have followed this narrative
8 users have commented on this narrative
1 users have liked this narrative
YI
ETSY logo
yiannisz on Etsy ·

Etsy Stock: Defending Differentiation in a World of Infinite Marketplaces

Fair Value:US$64.454.7% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.3% undervalued
69 users have followed this narrative
12 users have commented on this narrative
21 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25429.4% overvalued
71 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0226.0% undervalued
1023 users have followed this narrative
6 users have commented on this narrative
28 users have liked this narrative